NCT02468700View on ClinicalTrials.gov

OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

November 30, 2015

Conditions
Dry Eye
Interventions
DRUG

Dexamethasone

OTHER

Placebo Vehicle

Sponsors
All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Ocular Therapeutix, Inc.

INDUSTRY